Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03072329
Other study ID # PNB-001
Secondary ID
Status Completed
Phase N/A
First received February 25, 2017
Last updated March 6, 2017
Start date October 2016
Est. completion date March 1, 2017

Study information

Verified date March 2017
Source Hôpital d'enfants Béchir-Hamza
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to check whether the success rate of blind pudendal nerve block in penile surgery can be optimized by the search for a motor response during neurostimulation.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date March 1, 2017
Est. primary completion date February 20, 2017
Accepts healthy volunteers No
Gender Male
Age group 6 Months and older
Eligibility Inclusion Criteria:

- Children scheduled for elective penile surgery (hypospadias / circumcision)

Non-inclusion Criteria:

- Association to further peripheral nerve blocks required

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pudendal nerve block

Drug:
Bupivacaine


Locations

Country Name City State
Tunisia Hôpital d'Enfants Béchir Hamza Bab Saadoun Tunis

Sponsors (1)

Lead Sponsor Collaborator
Hôpital d'enfants Béchir-Hamza

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nerve block success Nerve block success is defined by the absence of 20% increase in heart rate or systolic blood pressure baseline values 15 minutes